Finding Balance: Multi-Objective Optimization in Molecular Generative Modeling

03 July 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Identifying novel therapeutics active towards a single target that balance requirements for potency, safety, metabolic stability and pharmacodynamic profile still presents a major challenge, which is further exacerbated by recent interest in designing compounds with properties that enable them to engage multiple targets. This entails trying balancing different, sometimes competing chemical features, which can be particularly challenging without the aid of computational methodologies. In this work, we leverage multi-objective optimization methods to help the design of novel small molecules optimised for conflicting pharmacological attributes with generative models. Across three case studies, we show that our approach is effective in generating de novo compounds predicted to have a good balance between desired properties, while also showing potential affinity to multiple targets, even when trained with limited public data. This offers a promising solution for overcoming limitations in drug discovery and design, especially when compounds with a well-balanced profile of conflicting features are needed.

Keywords

Generative AI
Reinforcement Learning
Multi-Objective Optimization
Drug Design

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.